Study Suggests that Spleen Artery Aneurysms May be more Common in Gaucher Disease than Previously Thought

According to a story from Gaucher Disease News, a recently published case report study suggests that instances of splenic artery aneurysm are being underreported in patients with Gaucher disease. The…

Continue Reading Study Suggests that Spleen Artery Aneurysms May be more Common in Gaucher Disease than Previously Thought
Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation
NeuPaddy / Pixabay

Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation

According to a story from Central Charts, the biopharmaceutical company Acceleron Pharma Inc. recently announced that the company's experimental drug candidate ACE-083 has earned Orphan Drug designation from the US…

Continue Reading Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation

Study Testing Gene Therapy for Charcot-Marie-Tooth Disease Earns Funding from MDA and CMTA

According to a story from The Muscular Dystrophy Association (MDA), the organization alongside the Charot-Marie-Tooth Association (CMTA) has awarded grant funding totaling $276,430 to a research study that will develop…

Continue Reading Study Testing Gene Therapy for Charcot-Marie-Tooth Disease Earns Funding from MDA and CMTA

Learn about The Dupuytren Research Group

The Dupuytren Research Group was founded ten years ago. Our original name was Dupuytren Foundation. Our original mission was simple: to advocate for Dupuytren patients. Providing patient education, physician education, connecting patients with patients,…

Continue Reading Learn about The Dupuytren Research Group
Kidney Disease Drug May Have Future Treating Mitochondrial Disorders
argzombies / Pixabay

Kidney Disease Drug May Have Future Treating Mitochondrial Disorders

A publication at Science Daily recently announced that findings from Children's Hospital of Philadelphia suggested that cysteamine bitartrate, already used for nephropathic cystinosis (a rare kidney disease), might potentially benefit patients…

Continue Reading Kidney Disease Drug May Have Future Treating Mitochondrial Disorders

New Resources Could Improve Drug Development for Fibrodysplasia Ossificans Progressiva

Ipsen has just announced that they will be acquiring Clementia Pharmaceuticals. This merging of companies is exciting for the rare community because it will strengthen the resources, knowledge-base, and overall…

Continue Reading New Resources Could Improve Drug Development for Fibrodysplasia Ossificans Progressiva
Theranexus Releases Early Data from its Narcolepsy Clinical Trial
PixelAnarchy / Pixabay

Theranexus Releases Early Data from its Narcolepsy Clinical Trial

According to a story from finanznachrichten.de, the biopharmaceutical company Theranexus has recently released preliminary results from a Phase II clinical trial that is testing the company's experimental product THN102. This…

Continue Reading Theranexus Releases Early Data from its Narcolepsy Clinical Trial